CULLEN/FROST BANKERS, INC. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
CULLEN/FROST BANKERS, INC. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2022$12,000
+500.0%
903
+622.4%
0.00%
Q4 2021$2,0000.0%1250.0%0.00%
Q3 2021$2,0000.0%1250.0%0.00%
Q2 2021$2,0000.0%1250.0%0.00%
Q1 2021$2,0000.0%1250.0%0.00%
Q4 2020$2,000
-66.7%
125
-63.9%
0.00%
Q3 2020$6,000
-85.0%
346
-84.4%
0.00%
-100.0%
Q2 2020$40,000
+900.0%
2,213
+647.6%
0.00%
Q1 2020$4,000
-55.6%
296
-37.9%
0.00%
Q4 2019$9,000
-78.0%
477
-79.8%
0.00%
-100.0%
Q3 2019$41,000
+5.1%
2,366
+6.6%
0.00%0.0%
Q2 2019$39,000
-69.5%
2,220
-64.7%
0.00%
-75.0%
Q1 2019$128,0006,2820.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Bartlett & Co. LLC 20,781$2960.01%
Valued Wealth Advisors LLC 231$3,5740.00%
BALDWIN BROTHERS LLC/MA 2,035$29,0390.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders